Fairmount Healthcare Fund L.P.
SEC CIK 1686157 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | Dir, See Remarks | 938.2K | $10.00M | — | 1 | 2021-09-21 | 2021-09-21 |
Most active insiders at VRDN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | $20.00M | — |
| 2 | Fairmount Healthcare Fund II GP LLC | Dir, 10% | $10.00M | — |
| 3 | Tousignant Jennifer | CLO | — | $419.0K |
| 4 | Harmon Seth | CFO | — | — |
| 5 | Tripuraneni Radhika | Chief Medical Off | — | — |
| 6 | Mahoney Stephen F. | Pres, CEO, Dir | — | — |
| 7 | Beetham Thomas W. | COO | — | — |
Fairmount Healthcare Fund L.P. made no open-market trades at VRDN in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-09-23 | 2021-09-21 | VRDN | Viridian Therapeutics, Inc.\DE | Fairmount Healthcare Fund L.P. | Dir, See Remarks | P - Purchase | $11.00 | +909.0K | 938.2K | +3,109% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations